Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5084390
Max Phase: Preclinical
Molecular Formula: C28H43NO26
Molecular Weight: 809.63
Molecule Type: Unknown
Associated Items:
ID: ALA5084390
Max Phase: Preclinical
Molecular Formula: C28H43NO26
Molecular Weight: 809.63
Molecule Type: Unknown
Associated Items:
Canonical SMILES: NCCOCCO[C@@H]1O[C@@H](C(=O)O)[C@@H](O[C@@H]2O[C@@H](C(=O)O)[C@@H](O[C@@H]3O[C@@H](C(=O)O)[C@@H](O[C@@H]4O[C@@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O
Standard InChI: InChI=1S/C28H43NO26/c29-1-2-47-3-4-48-25-11(36)7(32)14(18(53-25)22(41)42)50-27-13(38)9(34)16(20(55-27)24(45)46)51-28-12(37)8(33)15(19(54-28)23(43)44)49-26-10(35)5(30)6(31)17(52-26)21(39)40/h5-20,25-28,30-38H,1-4,29H2,(H,39,40)(H,41,42)(H,43,44)(H,45,46)/t5-,6-,7+,8+,9+,10+,11+,12+,13+,14-,15-,16-,17+,18+,19+,20+,25+,26+,27+,28+/m0/s1
Standard InChI Key: XLLOQUXCLFGRHW-JCOSJTSTSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 809.63 | Molecular Weight (Monoisotopic): 809.2073 | AlogP: -9.38 | #Rotatable Bonds: 16 |
Polar Surface Area: 440.36 | Molecular Species: ZWITTERION | HBA: 23 | HBD: 14 |
#RO5 Violations: 3 | HBA (Lipinski): 27 | HBD (Lipinski): 15 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 2.48 | CX Basic pKa: 9.44 | CX LogP: -9.77 | CX LogD: -19.86 |
Aromatic Rings: 0 | Heavy Atoms: 55 | QED Weighted: 0.06 | Np Likeness Score: 0.72 |
1. Shanthamurthy CD, Leviatan Ben-Arye S, Kumar NV, Yehuda S, Amon R, Woods RJ, Padler-Karavani V, Kikkeri R.. (2021) Heparan Sulfate Mimetics Differentially Affect Homologous Chemokines and Attenuate Cancer Development., 64 (6.0): [PMID:33683903] [10.1021/acs.jmedchem.0c01800] |
Source(1):